Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chai Gui Long Mu Tang is a Traditional Chinese Medicine (TCM) herbal formula primarily composed of Bupleurum (Chai Hu), Cinnamon twig (Gui Zhi), Fossil bone (Long Gu), and Oyster shell (Mu Li). It is currently being investigated by Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine for its potential to mitigate trastuzumab-induced cardiotoxicity in patients with breast cancer. The formula is a variation of the classic 'Chai Hu Jia Long Gu Mu Li Tang' and is traditionally used to soothe the liver, clear heat, and anchor the spirit to treat symptoms like palpitations and anxiety. In the context of oncology, it is hypothesized to provide cardioprotection by modulating oxidative stress and inflammatory pathways associated with HER2-targeted therapy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Chai Gui Long Mu Tang.